Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, HealthEquity's Enterprise Value is €7,263 Mil.
HealthEquity's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 was €303 Mil. Therefore, HealthEquity's EV-to-EBIT ratio for today is 24.00.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, HealthEquity's Enterprise Value is €7,263 Mil.
HealthEquity's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 was €435 Mil. Therefore, HealthEquity's EV-to-EBITDA ratio for today is 16.71.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, HealthEquity's Enterprise Value is €7,263 Mil.
HealthEquity's Revenue for the trailing twelve months (TTM) ended in Apr. 2026 was €1,144 Mil. Therefore, HealthEquity's EV-to-Revenue ratio for today is 6.35.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, HealthEquity's Enterprise Value is €7,263 Mil.
HealthEquity's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 was €377 Mil. Therefore, HealthEquity's EV-to-FCF ratio for today is 19.25.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
HealthEquity (FRA:2HE) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
HealthEquity's current Enterprise Value is €7,263 Mil.
HealthEquity's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €303 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
HealthEquity's current Enterprise Value is €7,263 Mil.
HealthEquity's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €435 Mil.
HealthEquity's current Enterprise Value is €7,263 Mil.
HealthEquity's Revenue for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,144 Mil.
HealthEquity's current Enterprise Value is €7,263 Mil.
HealthEquity's Cash Flow from Operations for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €419 Mil.
HealthEquity's current Enterprise Value is €7,263 Mil.
HealthEquity's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €377 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthEquity Enterprise Value Related Terms
HealthEquity Enterprise Value Historical Data
* Premium members only.
The historical data trend for HealthEquity's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2HE vs HNGE, TEM, TXG: Enterprise Value Comparison
For the Health Information Services subindustry, HealthEquity's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthEquity Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Enterprise Value distribution charts can be found below:
* The bar in red indicates where HealthEquity's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
HealthEquity's Enterprise Value for the fiscal year that ended in Jan. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthEquity (FRA:2HE) has a Enterprise Value of €7,263 Mil as of Jul. 01, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on HealthEquity and its competitors.
Is HealthEquity's Enterprise Value too high?
HealthEquity's current Enterprise Value is €7,263 Mil. Overall, HealthEquity has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Enterprise Value compare to HNGE and TEM?
HealthEquity's Enterprise Value of €7,263 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on HealthEquity and its competitors. HealthEquity's current Enterprise Value is €7,263 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current Enterprise Value of €7,263 Mil. The stock's GF Value™ is €87.33, compared to a current price of €76.50 — trading 12.4% below its estimated fair value. The current Enterprise Value is €7,263 Mil. HealthEquity's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Enterprise Value is €7,263 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthEquity (FRA:2HE) Overvalued in 2026?
Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued.
The current stock price of €76.50 is trading 12.4% below its estimated GF Value™ of €87.33.
Key valuation signals for FRA:2HE:
Enterprise Value: €7,263 Mil
GF Value™: €87.33 vs. price of €76.50 (12.4% below fair value)
No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
92GF Score
Get the complete analysis for FRA:2HE
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2HE has been successfully added to your 
